<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:idx="urn:atom-extension:indexing" xmlns:media="http://search.yahoo.com/mrss/" xmlns:gr="http://www.google.com/schemas/reader/atom/" idx:index="no" gr:dir="ltr"><!--
Content-type: Preventing XSRF in IE.

--><generator uri="http://www.google.com/reader">Google Reader</generator><id>tag:google.com,2005:reader/user/17361820582415157295/state/com.google/broadcast</id><title type="text">Herbal Science Research Abstracts</title><gr:continuation>CPTNxrWV0JUC</gr:continuation><author><name>Shayne</name></author><updated>2009-09-03T06:44:09Z</updated><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/herbalscienceabstracts" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="herbalscienceabstracts" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><subtitle type="html">Herbal-related abstracts from the National Library of Medicine</subtitle><feedburner:emailServiceId xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">herbalscienceabstracts</feedburner:emailServiceId><feedburner:feedburnerHostname xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">http://feedburner.google.com</feedburner:feedburnerHostname><entry gr:crawl-timestamp-msec="1251960249059"><id gr:original-id="PubMed:19712756">tag:google.com,2005:reader/item/889563363639c4e3</id><category term="Int Immunopharmacol" /><title type="html">Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.</title><published>2009-09-03T06:44:09Z</published><updated>2009-09-03T06:44:09Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=19712756&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=echinacea" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=19712756"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Int Immunopharmacol. 2009 Aug 24;&lt;/p&gt;
        &lt;p&gt;Authors:  Spelman K, Iiams-Hauser K, Cech NB, Taylor EW, Smirnoff N, Wenner CA&lt;/p&gt;
        &lt;p&gt;Certain fatty acid amides from Echinacea spp. have demonstrated moderate to high cannabinoid activity. As a result, CB2 activation is currently hypothesized to be the basis of activity for immunomodulation by Echinacea spp. PPARgamma, an orphan nuclear receptor and lipid sensor, is known to inhibit IL-2 production and be activated by fatty acid derivatives such as the endocannabinoids. In these investigations, we demonstrate that undeca-2E-ene-8,10-diynoic acid , an Echinacea angustifolia-derived alkylamide lacking affinity for the CB2 receptor, inhibits IL-2 secretion in Jurkat T cells through PPARgamma activity at low micromolar concentrations (330ng/mL). The IL-2 inhibition is reversed by the addition of the selective PPARgamma antagonist T0070907. Additionally, we show that that undeca-2-ene-8,10-diynoic acid stimulates 3T3-L1 differentiation, a process dependent on PPARgamma activity. These experiments demonstrate that PPARgamma is involved in T cell IL-2 inhibition by undeca-2-ene-8,10-diynoic acid and suggest that cytokine modulation by the alkylamides is due to polyvalent activity.&lt;/p&gt;
        &lt;p&gt;PMID: 19712756 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Spelman K, Iiams-Hauser K, Cech NB, Taylor EW, Smirnoff N, Wenner CA</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMechinacea"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMechinacea</id><title type="html">PubMed - Echinacea Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=echinacea" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1251960216664"><id gr:original-id="PubMed:19650152">tag:google.com,2005:reader/item/81f43461e30543b0</id><category term="Pharmacoepidemiol Drug Saf" /><title type="html">Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.</title><published>2009-09-03T06:43:36Z</published><updated>2009-09-03T06:43:36Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=19650152&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=eleuthero%20OR%20%22siberian%20ginseng%22%20OR%20%22eleutherococcus%20senticosus%22" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=19650152"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Pharmacoepidemiol Drug Saf. 2009 Aug 3;&lt;/p&gt;
        &lt;p&gt;Authors:  Jacobsson I, Jönsson AK, Gerdén B, Hägg S&lt;/p&gt;
        &lt;p&gt;PURPOSE: Although the safety information is limited, use of complementary and alternative medicine (CAM) products is not without risks. Spontaneous reporting systems may be used in the surveillance of these products. We describe the pattern of spontaneously reported CAM related adverse reactions submitted to the Swedish Medical Products Agency (MPA) and highlight areas of safety concern. METHODS: All adverse reactions spontaneously reported to MPA between 1987 and 2006, where at least one CAM substance was a suspected agent, were scrutinised. From each report information about the patient, adverse reaction/s, drug treatment/s, dosage, time relationship and outcome was retrieved. RESULTS: Among a total of 64 493 reports, 778 reports concerned 967 suspected adverse reactions related to 175 different CAM products. The main distribution of suspected adverse reactions was: urticaria (8.3%), exanthema (7.4%) and contact dermatitis (5.7%). The most reported CAM substances were purple coneflower (Echinacea purpurea) (8.1%), purple coneflower + siberian ginseng (Eleutherococcus senticosus) + malabar nut (Adhatoda vasica) (7.3%) and ginkgo leaf (Ginkgo biloba) (6.7%). In 221 reports, at least one reaction was categorised as serious, the most frequent being pulmonary embolism (1.7%), mixed liver reaction (2.8%), and anaphylactic reaction (2.0%). Eleven of the serious adverse reactions had a fatal outcome. CONCLUSIONS: CAM substances were associated with a variety of adverse reactions. Some of these have previously been unrecognised or poorly documented and suggest further investigations. By stimulating the reporting of adverse reactions of CAM products, the signal detection power of the spontaneous reporting system may increase further. Copyright (c) 2009 John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;
        &lt;p&gt;PMID: 19650152 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Jacobsson I, Jönsson AK, Gerdén B, Hägg S</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMeleuthero"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMeleuthero</id><title type="html">PubMed - Eleuthero Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=eleuthero%20OR%20%22siberian%20ginseng%22%20OR%20%22eleutherococcus%20senticosus%22" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1251960191670"><id gr:original-id="PubMed:19716299">tag:google.com,2005:reader/item/b7bc6a5b204e069f</id><category term="Bioorg Med Chem Lett" /><title type="html">Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.</title><published>2009-09-03T06:43:11Z</published><updated>2009-09-03T06:43:11Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=19716299&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=kava%20OR%20%22piper%20methysticum%22" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Bioorg Med Chem Lett. 2009 Aug 6;&lt;/p&gt;
        &lt;p&gt;Authors:  Shaik AA, Hermanson DL, Xing C&lt;/p&gt;
        &lt;p&gt;Nuclear factor-kappaB (NF-kappaB) is a transcription factor that plays an essential role in cancer development. The results of our recent chemopreventive study demonstrate that kava, a beverage in the South Pacific Islands, suppresses NF-kappaB activation in lung adenoma tissues, potentially a mechanism responsible for kava's chemopreventive activity. Methysticin is identified as a potent NF-kappaB inhibitor in kava with minimum toxicity. Other kava constituents, including four kavalactones of similar structures to methysticin, demonstrate minimum activities in inhibiting NF-kappaB.&lt;/p&gt;
        &lt;p&gt;PMID: 19716299 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Shaik AA, Hermanson DL, Xing C</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMkava"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMkava</id><title type="html">PubMed - Kava Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=kava%20OR%20%22piper%20methysticum%22" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1251960163129"><id gr:original-id="PubMed:19719333">tag:google.com,2005:reader/item/911f3208697aae09</id><category term="Drugs" /><title type="html">Interactions between herbal medicines and prescribed drugs: an updated systematic review.</title><published>2009-09-03T06:42:43Z</published><updated>2009-09-03T06:42:43Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=19719333&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=kava%20OR%20%22piper%20methysticum%22" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Interactions between herbal medicines and prescribed drugs: an updated systematic review.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Drugs. 2009;69(13):1777-98&lt;/p&gt;
        &lt;p&gt;Authors:  Izzo AA, Ernst E&lt;/p&gt;
        &lt;p&gt;The concomitant use of herbal medicines and pharmacotherapy is wide spread. We have reviewed the literature to determine the possible interactions between seven popular herbal medicines (ginkgo, St John's wort, ginseng, garlic, echinacea, saw palmetto and kava) and conventional drugs. Literature searches were performed using MEDLINE, Cochrane Library and EMBASE and we identified 128 case reports or case series, and 80 clinical trials. Clinical trials indicate that St John's wort (Hypericum perforatum), via cytochrome P450 (CYP) and/or P-glycoprotein induction, reduces the plasma concentrations (and/or increases the clearance) of alprazolam, amitriptyline, atorvastatin, chlorzoxazone, ciclosporin, debrisoquine, digoxin, erythromycin, fexofenadine, gliclazide, imatinib, indinavir, irinotecan, ivabradine, mephenytoin, methadone, midazolam, nifedipine, omeprazole, oral contraceptives, quazepam, simvastatin, tacrolimus, talinolol, verapamil, voriconazole and warfarin. Case reports or case series suggest interactions of St John's wort with adrenergic vasopressors, anaesthetics, bupropion, buspirone, ciclosporin, eletriptan, loperamide, nefazodone, nevirapine, oral contraceptives, paroxetine, phenprocoumon, prednisone, sertraline, tacrolimus, theophylline, tibolone, tryptophan, venlafaxine and warfarin. Ginkgo (Ginkgo biloba) decreases the plasma concentrations of omeprazole, ritonavir and tolbutamide. Clinical cases indicate interactions of ginkgo with antiepileptics, aspirin (acetylsalicylic acid), diuretics, ibuprofen, risperidone, rofecoxib, trazodone and warfarin. Ginseng (Panax ginseng) may interact with phenelzine and warfarin. Kava (Piper methysticum) increases the clearance of chlorzoxazone (a CYP2E1 substrate) and may interact with alprazolam, levodopa and paroxetine. Garlic (Allium sativum) interacts with chlorpropamide, fluindione, ritonavir and warfarin; it also reduces plasma concentrations of chlorzoxazone (a CYP2E1 probe). Echinacea might affect the clearance of caffeine (a CYP1A2 probe) and midazolam (a CYP3A4 probe). No interactions have been reported for saw palmetto (Serenoa repens). Numerous interactions between herbal medicines and conventional drugs have been documented. While the significance of many interactions is uncertain, several interactions, particularly those with St John's wort, may have serious clinical consequences.&lt;/p&gt;
        &lt;p&gt;PMID: 19719333 [PubMed - in process]&lt;/p&gt;</summary><author><name>Izzo AA, Ernst E</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMkava"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMkava</id><title type="html">PubMed - Kava Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=kava%20OR%20%22piper%20methysticum%22" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185753382"><id gr:original-id="PubMed:18981951">tag:google.com,2005:reader/item/e22a1ecf1fb1947b</id><category term="Menopause" /><title type="html">Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.</title><published>2008-11-08T23:09:13Z</published><updated>2008-11-08T23:09:13Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18981951&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28Menstrual%20Cycle%20OR%20Menstruation%20OR%20Menopause%29%20AND%20%28Natural%20Medicine%20OR%20Medicine%2CHerbal%20OR%20Phytotherapy%20OR%20Hydrotherapy%20OR%20Nutrition%20Therapy%20OR%20Naturopathy%20OR%20Medicine%2CNaturopathic%20OR%20Natural%20Medicines%20OR%20Natural%20Remedies%20OR%20Natural%20Products%20OR%20Plant%20Preparations%20OR%20Medicine%2CHerbal%20OR%20Plant%20Extracts%20OR%20Plants%2CMedicinal%20OR%20Phytosterols%20OR%20Herbal%20Teas%20OR%20Teas%2CHerbal%20OR%20Drugs%2CChinese%20Herbal%20OR%20Herb-Drug%20Interactions%20OR%20Vitamins%20OR%20Minerals%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18981951"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Menopause. 2008 Oct 31;&lt;/p&gt;
        &lt;p&gt;Authors:  Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S&lt;/p&gt;
        &lt;p&gt;OBJECTIVE:: After menopause, women experience changes in body composition, especially an increase in fat mass. In addition, advancing age, decreased physical activity, and increased inflammation may predispose them to develop type 2 diabetes. Isoflavones have been shown to improve metabolic parameters in postmenopausal women. However, the effect of isoflavones on adipokines/cytokines remains unclear. The purpose of this study was to evaluate the effect of high-dose isoflavones on inflammatory and metabolic markers in postmenopausal women. DESIGN:: We measured glucose, insulin, and adipokines/cytokines in 75 healthy postmenopausal women who were randomized to receive 20 g of soy protein with 160 mg of total isoflavones (64 mg genistein, 63 mg daidzein, and 34 mg glycitein) or 20 g of soy protein placebo for 12 weeks. Women taking estrogen discontinued therapy at least 3 months before the study. The supplements were given in a powder form and consumed once daily with milk or other beverages. RESULTS:: Mean ages in the placebo and active groups were similar (P = 0.4). Average time since menopause was 9 years, and two thirds of the women underwent natural menopause. There was no significant difference in body mass index at baseline between the groups (placebo, 25.1 kg/m; active, 26 kg/m) and it did not change significantly during the study. At baseline, the placebo group had significantly higher levels of tumor necrosis factor alpha (P &amp;lt; 0.0001); otherwise, there was no difference in any other parameter. After 12 weeks of treatment, there were significant positive changes in tumor necrosis factor alpha levels within the placebo group (P &amp;lt; 0.0001) and adiponectin levels within the isoflavone group (P = 0.03). Comparison of pre-post change between the groups showed a small but significant increase in serum adiponectin levels in the isoflavone group (P = 0.03) compared with the placebo group. No significant changes were seen in any other parameter between the two groups. CONCLUSIONS:: Healthy, normal-weight postmenopausal women may not experience improvement in metabolic parameters when given high-dose isoflavones despite an increase in serum adiponectin levels. The role of isoflavones in obese and insulin-resistant postmenopausal women needs exploration.&lt;/p&gt;
        &lt;p&gt;PMID: 18981951 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/iwhim"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/iwhim</id><title type="html">IWHIM Women&amp;#39;s Research Feed</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28Menstrual%20Cycle%20OR%20Menstruation%20OR%20Menopause%29%20AND%20%28Natural%20Medicine%20OR%20Medicine%2CHerbal%20OR%20Phytotherapy%20OR%20Hydrotherapy%20OR%20Nutrition%20Therapy%20OR%20Naturopathy%20OR%20Medicine%2CNaturopathic%20OR%20Natural%20Medicines%20OR%20Natural%20Remedies%20OR%20Natural%20Products%20OR%20Plant%20Preparations%20OR%20Medicine%2CHerbal%20OR%20Plant%20Extracts%20OR%20Plants%2CMedicinal%20OR%20Phytosterols%20OR%20Herbal%20Teas%20OR%20Teas%2CHerbal%20OR%20Drugs%2CChinese%20Herbal%20OR%20Herb-Drug%20Interactions%20OR%20Vitamins%20OR%20Minerals%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185725737"><id gr:original-id="PubMed:18758432">tag:google.com,2005:reader/item/9af6bcde6fb96dcf</id><category term="Med Sci Monit" /><title type="html">Homeopathic ethanol.</title><published>2008-11-08T23:08:45Z</published><updated>2008-11-08T23:08:45Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18758432&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18758432"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Homeopathic ethanol.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Med Sci Monit. 2008 Sep;14(9):SC11-3&lt;/p&gt;
        &lt;p&gt;Authors:  Kream RM, Stefano GB&lt;/p&gt;
        &lt;p&gt;Ethanol has had a long and deep association with the historical development of world culture. Ostensibly, its consumption has both short and long term positive and negative effects, based on moderate or excessive intake, respectively. The predominant thrust of empirical research, however, into the multiple biological effects of ethanol has led to its negative designation as a major addictive substance. Multiple lines of research have elucidated functional interactions of ethanol in opioid modulation of dopaminergic transmission in CNS reward systems. In parallel, recent work has demonstrated that animal cells have the ability to effect de novo synthesis of chemically authentic morphine from dopamine (DA) and DA-related aromatic precursor molecules. Interestingly, we have observed that sub-threshold concentrations of ethanol alter cellular distributions of endogenously expressed morphine. Reciprocal autocrine/paracrine modulatory effects of very low concentrations of morphine in concert with ethanol also suggest the potential for endogenous expression and action of homeopathic concentrations of ethanol within discrete cellular microdomains. Perturbation of this subtle regulatory relationship by exogenous intake of ethanol may shed light on the biochemical and molecular bases of reward and addictive states.&lt;/p&gt;
        &lt;p&gt;PMID: 18758432 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Kream RM, Stefano GB</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185641885"><id gr:original-id="PubMed:18985656">tag:google.com,2005:reader/item/054cd40ebc7ac01e</id><category term="Mol Nutr Food Res" /><title type="html">Tea, Coffee and Prostate Cancer.</title><published>2008-11-08T23:07:21Z</published><updated>2008-11-08T23:07:21Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18985656&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=green%20tea%20OR%20%22camellia%20sinensis%22" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18985656"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Tea, Coffee and Prostate Cancer.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Mol Nutr Food Res. 2008 Nov 4;&lt;/p&gt;
        &lt;p&gt;Authors:  Lee AH, Fraser ML, Binns CW&lt;/p&gt;
        &lt;p&gt;Worldwide, prostate cancer has the second highest incidence of all cancers in males with incidence and mortality being much higher in affluent developed countries. Risk and progression of the disease may be linked to both genetic and environmental factors, especially dietary factors. Tea and coffee are two of the most popular beverages in the world and have been investigated for possible effects on health outcomes, including cancer. However, very little dietary advice for their consumption exists. The evidence for a relationship between coffee or tea consumption and prostate cancer is reviewed in this paper. While current evidence indicates that coffee is a safe beverage, its consumption probably has no relationship with prostate cancer. Tea, especially green tea, has shown some potential in the prevention of prostate cancer. While evidence from epidemiologic studies is currently inconclusive, strong evidence has emerged from animal and in vitro studies. We also consider what level of evidence is required to make recommendations for preventive measures to the public. Although evidence on the relationship between coffee, tea and prostate cancer is not complete, we consider it strong enough to recommend tea as a healthier alternative to coffee.&lt;/p&gt;
        &lt;p&gt;PMID: 18985656 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Lee AH, Fraser ML, Binns CW</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMgreentea"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMgreentea</id><title type="html">PubMed - Green Tea Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=green%20tea%20OR%20%22camellia%20sinensis%22" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185634160"><id gr:original-id="PubMed:17959291">tag:google.com,2005:reader/item/6589852289839971</id><category term="Prog Neuropsychopharmacol Biol Psychiatry" /><title type="html">Withania somnifera: an Indian ginseng.</title><published>2008-11-08T23:07:14Z</published><updated>2008-11-08T23:07:14Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=17959291&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(07)00340-5"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=17959291"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Withania somnifera: an Indian ginseng.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1093-105&lt;/p&gt;
        &lt;p&gt;Authors:  Kulkarni SK, Dhir A&lt;/p&gt;
        &lt;p&gt;Withania somnifera, popularly known as Ashwagandha is widely considered as the Indian ginseng. In Ayurveda, it is classified as a rasayana (rejuvenation) and expected to promote physical and mental health, rejuvenate the body in debilitated conditions and increase longevity. Having wide range of activity, it is used to treat almost all disorders that affect the human health. The present review discusses the pharmacological basis of the use of W. somnifera in various central nervous system (CNS) disorders, particularly its indication in epilepsy, stress and neurodegenerative diseases such as Parkinson's and Alzheimer's disorders, tardive dyskinesia, cerebral ischemia, and even in the management of drug addiction.&lt;/p&gt;
        &lt;p&gt;PMID: 17959291 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Kulkarni SK, Dhir A</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmed"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmed</id><title type="html">Herbal Science Research - PubMed Abstracts</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185624922"><id gr:original-id="PubMed:18483011">tag:google.com,2005:reader/item/a19d55f66445fc41</id><category term="Int J Low Extrem Wounds" /><title type="html">Considerations for determining if a natural product is an effective wound-healing agent.</title><published>2008-11-08T23:07:04Z</published><updated>2008-11-08T23:07:04Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18483011&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18483011"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Considerations for determining if a natural product is an effective wound-healing agent.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Int J Low Extrem Wounds. 2008 Jun;7(2):75-81&lt;/p&gt;
        &lt;p&gt;Authors:  Lindblad WJ&lt;/p&gt;
        &lt;p&gt;Many research groups are examining natural products for their vulnerary activity. On the basis of the countless years of folklore and clinical observations, these preparations are being fractionated and applied to wounds in a variety of animal species. Despite this work, the number of agents that have documented ability to enhance wound healing is minimal. This article provides a brief review of some of the major historical milestones in wound care and provides a framework for studying plant products so as to achieve statistically significant results in biologically important models of healing. Only with the use of reference standards, data from appropriate animal models, and human trials can we begin to mine the great potential of these natural products.&lt;/p&gt;
        &lt;p&gt;PMID: 18483011 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Lindblad WJ</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmed"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmed</id><title type="html">Herbal Science Research - PubMed Abstracts</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185412185"><id gr:original-id="PubMed:18987767">tag:google.com,2005:reader/item/8a384e413c529195</id><category term="Can J Cardiol" /><title type="html">Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy.</title><published>2008-11-08T23:03:32Z</published><updated>2008-11-08T23:03:32Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18987767&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18987767"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Can J Cardiol. 2008 Nov;24(11):e86-8&lt;/p&gt;
        &lt;p&gt;Authors:  Akay S, Ozdemir M&lt;/p&gt;
        &lt;p&gt;Pseudoephedrine, a common ingredient in cold relief drugs, dietary supplements and Chinese herbal tea, has potent sympathomimetic effects, impacting the cardiovascular system. The chemical properties and clinical effects of pseudoephedrine are similar to those of ephedrine, and its main effect is caused by the release of endogenous norepinephrine. A 45-year-old man who presented with chest pain following ingestion of pseudoephedrine--containing prescription medication is described. The patient was initially diagnosed with inferior myocardial infarction based on an electrocardiogram, and intravenous metoprolol was started pending coronary artery angiography. Metoprolol reversed the ST segment elevation and relieved the symptoms, and coronary angiography showed normal coronary arteries. The present case highlights beta-blocker therapy as part of an initial intervention of pseudoephedrine-related cardiac symptoms.&lt;/p&gt;
        &lt;p&gt;PMID: 18987767 [PubMed - in process]&lt;/p&gt;</summary><author><name>Akay S, Ozdemir M</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmed"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmed</id><title type="html">Herbal Science Research - PubMed Abstracts</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185355819"><id gr:original-id="PubMed:18989760">tag:google.com,2005:reader/item/2fb2cb7d02d4ed6f</id><category term="Pharm Res" /><title type="html">Blocking Effect of an Immuno-Suppressive Agent, Cynarin, on CD28 of T-Cell Receptor.</title><published>2008-11-08T23:02:35Z</published><updated>2008-11-08T23:02:35Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18989760&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=echinacea" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://dx.doi.org/10.1007/s11095-008-9754-5"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--production.springer.de-OnlineResources-Logos-springerlink.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18989760"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Blocking Effect of an Immuno-Suppressive Agent, Cynarin, on CD28 of T-Cell Receptor.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Pharm Res. 2008 Nov 7;&lt;/p&gt;
        &lt;p&gt;Authors:  Dong GC, Chuang PH, Chang KC, Jan PS, Hwang PI, Wu HB, Yi M, Zhou HX, Chen HM&lt;/p&gt;
        &lt;p&gt;PURPOSE: Cynarin, a potential immunosuppressant that blocks the interaction between the CD28 of T-cell receptor and CD80 of antigen presenting cells, was found in Echinacea purpurea by a new pharmaceutical screening method: After Flowing Through Immobilized Receptor (AFTIR; Dong et al., J Med Chem, 49: 1845-1854, 2006). This Echinacea component is the first small molecule that is able to specifically block "signal 2" of T-cell activation. METHODS: In this study, we used the AFTIR method to further confirm that cynarin effectively blocked the binding between CD80 of B-cells and CD28 of T-cells, and provide details of its mechanism of action. RESULTS: The experimental results showed that cynarin blocked about 87% of the CD28-dependent "signal 2" pathway of T-cell activation under the condition of one to one ratio of T-cell and B-cell in vitro. Theoretical structure modeling showed that cynarin binds to the "G-pocket" of CD28 (Evans et al., Nat Immunol, 6:271-279, 2005), and thus interrupts the site of interaction between CD28 and CD80. CONCLUSIONS: These results confirm both that AFTIR is a promising method for screening selective active compounds from herbal medicine and that cynarin has great potential as an immuno-suppressive agent.&lt;/p&gt;
        &lt;p&gt;PMID: 18989760 [PubMed - as supplied by publisher]&lt;/p&gt;</summary><author><name>Dong GC, Chuang PH, Chang KC, Jan PS, Hwang PI, Wu HB, Yi M, Zhou HX, Chen HM</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMechinacea"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMechinacea</id><title type="html">PubMed - Echinacea Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=echinacea" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185312186"><id gr:original-id="PubMed:18553042">tag:google.com,2005:reader/item/ced45049cf964b55</id><category term="Calcif Tissue Int" /><title type="html">Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women.</title><published>2008-11-08T23:01:52Z</published><updated>2008-11-08T23:01:52Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18553042&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28Menstrual%20Cycle%20OR%20Menstruation%20OR%20Menopause%29%20AND%20%28Natural%20Medicine%20OR%20Medicine%2CHerbal%20OR%20Phytotherapy%20OR%20Hydrotherapy%20OR%20Nutrition%20Therapy%20OR%20Naturopathy%20OR%20Medicine%2CNaturopathic%20OR%20Natural%20Medicines%20OR%20Natural%20Remedies%20OR%20Natural%20Products%20OR%20Plant%20Preparations%20OR%20Medicine%2CHerbal%20OR%20Plant%20Extracts%20OR%20Plants%2CMedicinal%20OR%20Phytosterols%20OR%20Herbal%20Teas%20OR%20Teas%2CHerbal%20OR%20Drugs%2CChinese%20Herbal%20OR%20Herb-Drug%20Interactions%20OR%20Vitamins%20OR%20Minerals%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://dx.doi.org/10.1007/s00223-008-9148-z"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--production.springer.de-OnlineResources-Logos-springerlink.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18553042"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Calcif Tissue Int. 2008 Aug;83(2):81-4&lt;/p&gt;
        &lt;p&gt;Authors:  Thomas SD, Need AG, Tucker G, Slobodian P, O'Loughlin PD, Nordin BE&lt;/p&gt;
        &lt;p&gt;This study was conducted to compare the suppressive effects of calcium carbonate and calcium citrate on bone resorption in early postmenopause. Calcium citrate is thought to be better absorbed. We therefore tested the hypothesis that calcium as citrate is more effective than calcium as carbonate in suppressing parathyroid hormone (PTH) and C-terminal telopeptide. Twenty-five healthy postmenopausal women were recruited in this double blind crossover study. The subjects were randomly allocated to receive either 1,000 mg of elemental calcium as carbonate or 500 mg of calcium as citrate. They were given the alternate calcium dose 1 week later. Serum measurements of total and ionized calcium, phosphate, PTH, and CrossLaps were repeated 12 hours after each dose. Analysis of variance found no significant difference between measures for the two salts. Tests for equivalence indicated that 500 mg of calcium citrate may be superior to 1,000 mg of calcium carbonate in raising serum total and ionized calcium (P = 0.04 and 0.05, respectively). For all parameters measured, 500 mg of calcium citrate was at least as beneficial as 1,000 mg of calcium carbonate. Calcium citrate is at least as effective as calcium carbonate in suppressing PTH and C-terminal telopeptide cross-links, at half the dose. This may be because calcium as citrate is better absorbed than calcium as carbonate. If calcium citrate can be used in lower doses, it may be better tolerated than calcium carbonate.&lt;/p&gt;
        &lt;p&gt;PMID: 18553042 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Thomas SD, Need AG, Tucker G, Slobodian P, O'Loughlin PD, Nordin BE</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/iwhim"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/iwhim</id><title type="html">IWHIM Women&amp;#39;s Research Feed</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28Menstrual%20Cycle%20OR%20Menstruation%20OR%20Menopause%29%20AND%20%28Natural%20Medicine%20OR%20Medicine%2CHerbal%20OR%20Phytotherapy%20OR%20Hydrotherapy%20OR%20Nutrition%20Therapy%20OR%20Naturopathy%20OR%20Medicine%2CNaturopathic%20OR%20Natural%20Medicines%20OR%20Natural%20Remedies%20OR%20Natural%20Products%20OR%20Plant%20Preparations%20OR%20Medicine%2CHerbal%20OR%20Plant%20Extracts%20OR%20Plants%2CMedicinal%20OR%20Phytosterols%20OR%20Herbal%20Teas%20OR%20Teas%2CHerbal%20OR%20Drugs%2CChinese%20Herbal%20OR%20Herb-Drug%20Interactions%20OR%20Vitamins%20OR%20Minerals%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185303704"><id gr:original-id="PubMed:18990744">tag:google.com,2005:reader/item/81fb389f4d60f48c</id><category term="Cancer Epidemiol Biomarkers Prev" /><title type="html">Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.</title><published>2008-11-08T23:01:43Z</published><updated>2008-11-08T23:01:43Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18990744&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=green%20tea%20OR%20%22camellia%20sinensis%22" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://cebp.aacrjournals.org/cgi/pmidlookup?view=long&amp;amp;pmid=18990744"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-standard-cebp_final.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18990744"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3020-5&lt;/p&gt;
        &lt;p&gt;Authors:  Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H&lt;/p&gt;
        &lt;p&gt;BACKGROUND: Experimental studies indicate the chemopreventive properties of green tea extract (GTE) on colorectal cancer. Epidemiologically, green tea consumption of &amp;gt;10 cups daily reduced colorectal cancer risk in Japanese. Because colorectal adenomas are the precursors to most sporadic colorectal cancers, we conducted a randomized trial to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by raising green tea consumption in the target population from an average of 6 cups (1.5 g GTE) daily to &amp;gt;/=10 cups equivalent (2.5 g GTE) by supplemental GTE tablets. METHODS: We recruited 136 patients, removed their colorectal adenomas by endoscopic polypectomy, and 1 year later confirmed the clean colon (i.e., no polyp) at the second colonoscopy. The patients were then randomized into two groups while maintaining their lifestyle on green tea drinking: 71 patients supplemented with 1.5 g GTE per day for 12 months and 65 control patients without supplementation. Follow-up colonoscopy was conducted 12 months later in 125 patients (65 in the control group and 60 in the GTE group). RESULTS: The incidence of metachronous adenomas at the end-point colonoscopy was 31% (20 of 65) in the control group and 15% (9 of 60) in the GTE group (relative risk, 0.49; 95% confidence interval, 0.24-0.99; P &amp;lt; 0.05). The size of relapsed adenomas was also smaller in the GTE group than in the control group (P &amp;lt; 0.001). No serious adverse events occurred in the GTE group. CONCLUSION: GTE is an effective supplement for the chemoprevention of metachronous colorectal adenomas. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3020-5).&lt;/p&gt;
        &lt;p&gt;PMID: 18990744 [PubMed - in process]&lt;/p&gt;</summary><author><name>Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/PMgreentea"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/PMgreentea</id><title type="html">PubMed - Green Tea Research</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=green%20tea%20OR%20%22camellia%20sinensis%22" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185271927"><id gr:original-id="PubMed:18989142">tag:google.com,2005:reader/item/54c6da3f496e9378</id><category term="Eur J Gastroenterol Hepatol" /><title type="html">Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.</title><published>2008-11-08T23:01:11Z</published><updated>2008-11-08T23:01:11Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18989142&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00042737-200812000-00009"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--www.lwwonline.com-pt-pt-core-template-journal-lwwgateway-images-pmlogo.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18989142"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1182-93&lt;/p&gt;
        &lt;p&gt;Authors:  Teschke R, Schwarzenboeck A, Hennermann KH&lt;/p&gt;
        &lt;p&gt;BACKGROUND/AIMS: Hepatotoxicity has been previously suspected by national regulatory agencies in 26 patients in causal relationship with the treatment by kava extracts commonly used as herbal anxiolytic drugs. METHODS: A quantitative causality assessment was undertaken using the system of the Council for International Organizations of Medical Sciences, scale of objective probability scoring. RESULTS: Causality was unassessable, unrelated, or excluded in 16 patients owing to lack of temporal association and causes independent of kava or comedicated drugs. Low Council for International Organizations of Medical Sciences scores additionally resulted in excluded or unlikely causality assessments (n=2), leaving a total of eight patients with various degrees of causality for kava +/- comedicated drugs. Only one out of these eight patients adhered to the regulatory recommendations regarding both daily dose (&amp;lt;or=120 mg kavapyrones) and duration of therapy (&amp;lt;or=3 months) and experienced toxic liver injury with a probable causality for kava. In six cases with kava overdose and/or increased duration of kava treatment causality for kava was possible (n=3) and for kava together with the comedicated drug(s) possible (n=2) or probable (n=1). CONCLUSION: Kava taken as recommended is associated with rare hepatotoxicity, whereas overdose, prolonged treatment, and comedication may carry an increased risk.&lt;/p&gt;
        &lt;p&gt;PMID: 18989142 [PubMed - in process]&lt;/p&gt;</summary><author><name>Teschke R, Schwarzenboeck A, Hennermann KH</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmed"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmed</id><title type="html">Herbal Science Research - PubMed Abstracts</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1226185126969"><id gr:original-id="PubMed:18990044">tag:google.com,2005:reader/item/655edd1f9fe1a766</id><category term="J Altern Complement Med" /><title type="html">Pharmaco-physio-psychologic effect of Ayurvedic oil-dripping treatment using an essential oil from Lavendula angustifolia.</title><published>2008-11-08T22:58:46Z</published><updated>2008-11-08T22:58:46Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18990044&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18990044"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Pharmaco-physio-psychologic effect of Ayurvedic oil-dripping treatment using an essential oil from Lavendula angustifolia.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;J Altern Complement Med. 2008 Oct;14(8):947-56&lt;/p&gt;
        &lt;p&gt;Authors:  Xu F, Uebaba K, Ogawa H, Tatsuse T, Wang BH, Hisajima T, Venkatraman S&lt;/p&gt;
        &lt;p&gt;Ayurvedic oil-dripping treatment, Shirodhara, involves the use of medicated herbal sesame oils. In our previous reports, we found that Shirodhara with plain sesame oil induced anxiolysis and an altered state of consciousness (ASC) in healthy subjects. We studied the pharmaco-physio-psychologic effect of Shirodhara with medicated sesame oil including an essential oil from Lavendula angustifolia (lavender) in the present study. Sixteen (16) healthy females (38 +/- 8 years old) were assigned at random to three treatments applied by a robotic oil-dripping system: plain sesame oil (plain Shirodhara), medicated sesame oil with a 0.3 volume % of lavender essential oil (lavender Shirodhara), or the control supine position. Psychophysiologic parameters including the heart rate, skin temperature of the dorsum of hands and feet, as well as anxiety and ASC were monitored, and the rates of change of these items were calculated to assess the psychophysiologic changes brought about by Shirodhara. Lavender Shirodhara showed potent anxiolytic and ASC-inducing or promoting effects, and induced the largest increase in foot skin temperature. The correlation between anxiolysis and ASC, as well as the correlation between these psychologic effects and the elevated foot skin temperature were larger in the lavender Shirodhara than in the other two conditions. It was speculated that the psycho-physiologic effects of lavender Shirodhara would be brought about by three mechanisms: (1) the well-known relaxing action of essential oils from L. angustifolia mediated by olfactory nerves, (2) the pharmacologic action of substances absorbed through the skin or mucosa in the sesame oil or lavender essential oil, and (3) the physiologic effect of sesame oil dripped on the forehead induced by the somato-autonomic reflex through thermosensors or pressure sensors in the skin or hair follicles via the trigeminal cranial nerve. The complicated pharmaco-physio-psychologic action of Ayurvedic oil treatment may provide a useful model for future pharmaco-physio-psychotherapy.&lt;/p&gt;
        &lt;p&gt;PMID: 18990044 [PubMed - in process]&lt;/p&gt;</summary><author><name>Xu F, Uebaba K, Ogawa H, Tatsuse T, Wang BH, Hisajima T, Venkatraman S</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmed"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmed</id><title type="html">Herbal Science Research - PubMed Abstracts</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%28herbal%20OR%20phytotherapy%20OR%20herbals%20OR%20herbalism%20OR%20botanical%20OR%20botanicals%20OR%20herbal%20medicine%20OR%20chinese%20herbal%20drugs%20OR%20herbal%20drugs%20OR%20medicinal%20plants%20OR%20plant%20extracts%20OR%20eclecticism%20OR%20kneipp%20OR%20kneipp%20S%29%20AND%20%28medicinal%20OR%20remedy%20OR%20remedies%20OR%20therapy%20OR%20therapeutic%20use%20OR%20treatment%20OR%20preparation%20OR%20preparations%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1221014739208"><id gr:original-id="PubMed:18416476">tag:google.com,2005:reader/item/6e2e3c6a34c857a8</id><category term="World J Gastroenterol" /><title type="html">Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients.</title><published>2008-09-10T02:45:39Z</published><updated>2008-09-10T02:45:39Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18416476&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://www.wjgnet.com/1007-9327/14/2434.asp"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--www.wjgnet.com-images-wjg.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18416476"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;World J Gastroenterol. 2008 Apr 21;14(15):2434-9&lt;/p&gt;
        &lt;p&gt;Authors:  Liang B, Wang S, Ye YJ, Yang XD, Wang YL, Qu J, Xie QW, Yin MJ&lt;/p&gt;
        &lt;p&gt;AIM: To investigate the effect of omega-3 fatty acid parenteral supplementation postoperatively on clinical outcomes and immunomodulation in colorectal cancer patients. METHODS: Forty-two patients undergoing radical colorectal cancer resection with an indication for total parenteral nutrition postoperatively were enrolled in this prospective, double-blind, randomized, controlled study. Patients received total parenteral nutrition supplemented with either soybean oil (LCT; Intralipid, Fresenius-Kabi, SO group, n = 21) or a combination of omega-3 fish oil and soybean oil (LCT:fish oil = 5:1, fish oil; Omegaven, Fresenius-Kabi, FO group, n = 21), up to a total of 1.2 g lipid/kg per day for 7 d postoperatively. A same volume calorie and nitrogen was administrated. Routine blood test, biochemistry, systemic levels of IL-6 and TNF-alpha, percentage of CD3+, CD4+, and CD8+ lymphocytes were evaluated preoperatively and on postoperative d 1 and 8. Patient outcome was evaluated considering mortality during the hospital stay, length of postoperative hospital stay, and occurrence of infectious complications. RESULTS: Both lipid regimens were well tolerated. No differences between the two groups were noticed in demographics, baseline blood test, biochemistry, serum levels of IL-6 and TNF-alpha, percentage of CD4+, CD8+ lymphocytes, and ratios of CD4+/CD8+. Compared with those on postoperative d 1, serum IL-6 levels on postoperative d 8 were significantly depressed in the FO group than in the reference group (-44.43 +/- 30.53 vs -8.39 +/- 69.08, P = 0.039). Simultaneously, the ratios of CD4+/CD8+ were significantly increased in the FO group (0.92 +/- 0.62 vs 0.25 +/- 1.22, P = 0.035). In addition, depression of serum TNF-alpha levels (-0.82 +/- 2.71 vs 0.27 +/- 1.67, P = 0.125) and elevation of CD3+ and CD4+ lymphocyte percentage (12.85 +/- 11.61 vs 3.84 +/- 19.62, P = 0.081, 17.80 +/- 10.86 vs 9.66 +/- 17.55, P = 0.084, respectively) were higher in the FO group than in the reference group. Patients in the FO group tended to need a shorter postoperative hospital stay (17.45 +/- 4.80 d vs 19.62 +/- 5.59 d, P = 0.19). No statistically significant difference was found when stratified to mortality and occurrence of infectious complications. CONCLUSION: Postoperative supplementation of omega-3 fatty acids may have a favorable effect on the outcomes in colorectal cancer patients undergoing radical resection by lowering the magnitude of inflammatory responses and modulating the immune response.&lt;/p&gt;
        &lt;p&gt;PMID: 18416476 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Liang B, Wang S, Ye YJ, Yang XD, Wang YL, Qu J, Xie QW, Yin MJ</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1221014321526"><id gr:original-id="PubMed:18533025">tag:google.com,2005:reader/item/eec9ae49e09a8051</id><category term="BMC Cancer" /><title type="html">Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.</title><published>2008-09-10T02:38:41Z</published><updated>2008-09-10T02:38:41Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18533025&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://www.biomedcentral.com/1471-2407/8/161"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--www.biomedcentral.com-graphics-pubmed-bmc.gif" border="0"&gt;&lt;/a&gt; &lt;a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18533025"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--www.pubmedcentral.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18533025"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;BMC Cancer. 2008;8:161&lt;/p&gt;
        &lt;p&gt;Authors:  Elluru SR, van Huyen JP, Delignat S, Kazatchkine MD, Friboulet A, Kaveri SV, Bayry J&lt;/p&gt;
        &lt;p&gt;BACKGROUND: Viscum album (VA) preparations have been used as a complimentary therapy in cancer. In addition to their cytotoxic properties, they have also been shown to have immunostimulatory properties. In the present study, we examine the hypothesis that the VA preparations induce activation of human DC that facilitates effective tumor regression. METHODS: Four day old monocyte-derived immature DCs were treated with VA Qu Spez at 5, 10 and 15 microg/ml for 48 hrs. The expression of surface molecules was analyzed by flow cytometry. The ability of Qu Spez-educated DC to stimulate T cells was analyzed by allogeneic mixed lymphocyte reaction and activation of Melan-A/MART-1-specific M77-80 CD8+T cells. Cytokines in cell free culture supernatant was analyzed by cytokine bead array assay. RESULTS: VA Qu Spez stimulated DCs presented with increased expression of antigen presenting molecule HLA-DR and of co-stimulatory molecules CD40, CD80 and CD86. The VA Qu Spez also induced the secretion of inflammatory cytokines IL-6 and IL-8. Further, Qu Spez-educated DC stimulated CD4+T cells in a allogeneic mixed lymphocyte reaction and activated melanoma antigen Melan-A/MART-1-specific M77-80 CD8+T cells as evidenced by increased secretion of TNF-alpha and IFNgamma. CONCLUSION: The VA preparations stimulate the maturation and activation of human DCs, which may facilitate anti-tumoral immune responses. These results should assist in understanding the immunostimulatory properties of VA preparations and improving the therapeutic strategies.&lt;/p&gt;
        &lt;p&gt;PMID: 18533025 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Elluru SR, van Huyen JP, Delignat S, Kazatchkine MD, Friboulet A, Kaveri SV, Bayry J</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1221014237151"><id gr:original-id="PubMed:18540093">tag:google.com,2005:reader/item/720ba73fc1d59067</id><category term="Biosci Biotechnol Biochem" /><title type="html">Characterization and antioxidative properties of oligomeric proanthocyanidin from prunes, dried fruit of Prunus domestica L.</title><published>2008-09-10T02:37:17Z</published><updated>2008-09-10T02:37:17Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18540093&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/bbb/70823?from=PubMed"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--linkout.jstage.jst.go.jp-logo.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18540093"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Characterization and antioxidative properties of oligomeric proanthocyanidin from prunes, dried fruit of Prunus domestica L.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Biosci Biotechnol Biochem. 2008 Jun;72(6):1615-8&lt;/p&gt;
        &lt;p&gt;Authors:  Kimura Y, Ito H, Kawaji M, Ikami T, Hatano T&lt;/p&gt;
        &lt;p&gt;A prune extract was separated by an antioxidant-guided assay to obtain an oligomeric proanthocyanidin fraction. The antioxidative oligomer was characterized as a procyanidin oligomer with an average polymerization degree of five and composed of epicatechin and catechin units. The antioxidative activity of the oligomer showed greater potency than chlorogenic acid which is known as an antioxidative component in prunes.&lt;/p&gt;
        &lt;p&gt;PMID: 18540093 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Kimura Y, Ito H, Kawaji M, Ikami T, Hatano T</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1221013855420"><id gr:original-id="PubMed:18591780">tag:google.com,2005:reader/item/ce20221704ad40e0</id><category term="Biol Pharm Bull" /><title type="html">Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats.</title><published>2008-09-10T02:30:55Z</published><updated>2008-09-10T02:30:55Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18591780&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.1387?from=PubMed"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--linkout.jstage.jst.go.jp-logo.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18591780"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Biol Pharm Bull. 2008 Jul;31(7):1387-91&lt;/p&gt;
        &lt;p&gt;Authors:  Chen N, Chiu PY, Ko KM&lt;/p&gt;
        &lt;p&gt;Schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, has been shown to enhance mitochondrial antioxidant status in liver, heart and brain tissues in rodents. Whether or not long-term Sch B treatment can protect against oxidative stress-induced cerebral damage remains unclear. In the present study, the effect of long-term Sch B treatment (1-30 mg/kg/dx15) on cerebral ischemia/reperfusion (I/R) injury was examined in rats. Sch B treatment protected against I/R-induced cerebral damage, as evidenced by the significant increase in the percentage of 2,3,5-triphenyl tetrazolium chloride (TTC)-stained tissues in representative brain slices, when compared with the Sch B-untreated and I/R control. The cerebroprotection was associated with an enhancement in cerebral mitochondrial antioxidant status, as assessed by the level/activity of reduced glutathione, alpha-tocopherol and Mn-superoxide dismutase, as well as the improvement/preservation of mitochondrial structural integrity, as assessed by the extents of malondialdehyde production, Ca(2+) loading and cytochrome c release, as well as the sensitivity to Ca(2+)-induced permeability transition, in control and I/R-challenged rats. In conclusion, long-term Sch B treatment could enhance cerebral mitochondrial antioxidant status as well as improve mitochondrial structural integrity, thereby protecting against I/R injury.&lt;/p&gt;
        &lt;p&gt;PMID: 18591780 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Chen N, Chiu PY, Ko KM</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry><entry gr:crawl-timestamp-msec="1221013806965"><id gr:original-id="PubMed:18591785">tag:google.com,2005:reader/item/98513459a771a2f2</id><category term="Biol Pharm Bull" /><title type="html">Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats.</title><published>2008-09-10T02:30:06Z</published><updated>2008-09-10T02:30:06Z</updated><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=18591785&amp;dopt=Abstract" type="text/html" /><summary xml:base="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="html">&lt;table border="0" width="100%"&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.1415?from=PubMed"&gt;&lt;img src="http://www.ncbi.nlm.nih.gov/entrez/query/egifs/http:--linkout.jstage.jst.go.jp-logo.gif" border="0"&gt;&lt;/a&gt; &lt;/td&gt;&lt;td align="right"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;amp;cmd=Display&amp;amp;dopt=PubMed_PubMed&amp;amp;from_uid=18591785"&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats.&lt;/b&gt;&lt;/p&gt;
        &lt;p&gt;Biol Pharm Bull. 2008 Jul;31(7):1415-21&lt;/p&gt;
        &lt;p&gt;Authors:  Kim SJ, Jung JY, Kim HW, Park T&lt;/p&gt;
        &lt;p&gt;This study evaluates the protective effect of Juniperus chinensis hot water extract (JCE) against high-fat-diet (HFD)-induced obesity and its molecular mechanisms in the visceral adipose tissue of rats. JCE supplementation significantly lowered body weight gain, visceral fat-pad weights, blood lipid levels, and blood insulin and leptin levels of rats rendered obese by an HFD. Feeding with JCE significantly reversed the HFD-induced down-regulation of the epididymal adipose tissue genes implicated in adipogenesis, such as the peroxisome proliferator-activated receptors gamma2 (PPARgamma2), adipocyte protein 2 (aP2), sterol regulatory element binding protein 1c (SREBP1c), fatty acid synthase (FAS), and HMG-CoA reductase (HMGR), as well as those involved in uncoupled respiration, such as the uncoupling protein 2 (UCP2) and uncoupling protein 3 (UCP3). Dietary supplementation with JCE also reversed the HFD-induced decreases in the AMP-activated protein kinase (AMPK) and the acetyl-CoA carboxylase 2 (ACC2) expressions at both the mRNA and protein levels and restored the HFD-induced inhibitions in the AMPK and ACC2 phosphorylation, which are related to fatty acid beta-oxidation, in the epididymal adipose tissue. This study reports, for the first time, that the JCE can have an anti-obesity effect in a rodent model with HFD-induced obesity through an enhanced gene transcription of the uncoupling protein as well as an elevated AMPK protein expression and phosphorylation in the visceral adipose tissue.&lt;/p&gt;
        &lt;p&gt;PMID: 18591785 [PubMed - indexed for MEDLINE]&lt;/p&gt;</summary><author><name>Kim SJ, Jung JY, Kim HW, Park T</name></author><source gr:stream-id="feed/http://feeds.feedburner.com/pubmedfulltext"><id>tag:google.com,2005:reader/feed/http://feeds.feedburner.com/pubmedfulltext</id><title type="html">Herbal Science Research - PubMed Full Text</title><link rel="alternate" href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Plant%20Preparations%22%5BMESH%5D%20OR%20%22Medicine%2C%20Herbal%22%5BMESH%5D%20OR%20%22Plant%20Extracts%22%5BMESH%5D%20OR%20%22Plants%2C%20Medicinal%22%5BMESH%5D%20OR%20%22Plants%22%5BMESH%5D%20OR%20%22Phytotherapy%22%5BMESH%5D%20OR%20%22Medicine%2C%20Traditional%22%5BMESH%5D%20OR%20%22Homeopathy%22%5BMESH%5D%20OR%20%22Ethnopharmacology%22%5BMESH%5D%20OR%20%22Phytosterols%22%5BMESH%5D%20AND%20%28free%20full%20text%5Bsb%5D%29" type="text/html" /></source></entry></feed>
